Donor‐specific Immune Regulation by CD8+ Lymphocytes Expanded from Rejecting Human Cardiac Allografts

To assess whether regulatory T cells are present in rejecting human cardiac allografts, we performed functional analyses of graft lymphocytes (GLs) expanded from endomyocardial biopsies (EMB; n = 5) with histological signs of acute cellular rejection. The GL cultures were tested for their proliferative capacity and regulatory activity on allogeneic‐stimulated peripheral blood mononuclear cells (PBMC) of the patient (ratio PBMC:GLs = 5:1). Three of these GL cultures were hyporesponsive to donor antigens and suppressed the antidonor proliferative T‐cell response of PBMC, but not the anti‐third‐party response. Interestingly, it was the CD8+ GL subset of these cultures that inhibited the antidonor response (65–91% inhibition of the proportion of proliferating cells); the CD4+ GLs of the expanded GL cultures were not suppressive. In conclusion, CD8+ GLs expanded from rejecting human cardiac allografts can exhibit donor‐specific immune regulatory activities in vitro. We suggest that during acute cellular rejection, GLs may not only consist of graft‐destructing effector T cells, but also of cells of the CD8+ type with the potential to specifically inhibit antidonor immune reactivity.

[1]  A. Thomson,et al.  New Insights into Mechanisms of Spontaneous Liver Transplant Tolerance: The Role of Foxp3‐Expressing CD25+CD4+ Regulatory T Cells , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  W. Weimar,et al.  Regulatory T cells after organ transplantation: where does their action take place? , 2008, Human immunology.

[3]  G. Jhangri,et al.  FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable Outcomes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  W. Weimar,et al.  The control of anti-donor immune responses by regulatory T cells in organ transplant patients. , 2008, Transplantation proceedings.

[5]  Lloyd J. Old,et al.  CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer , 2007, Clinical Cancer Research.

[6]  M. Ghoneim,et al.  An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  W. Weimar,et al.  Intragraft FOXP3 mRNA Expression Reflects Antidonor Immune Reactivity in Cardiac Allograft Patients , 2007, Transplantation.

[8]  R. Colvin,et al.  Pathological and Clinical Correlates of FOXP3+ Cells in Renal Allografts during Acute Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  Jean Kanitakis,et al.  Isolation of Regulatory T Cells in the Skin of a Human Hand-Allograft, Up to Six Years Posttransplantation , 2006, Transplantation.

[10]  W. Weimar,et al.  FoxP3+ T cells can be expanded from rejecting cardiac allografts. , 2006, Transplantation proceedings.

[11]  Nitin J. Karandikar,et al.  Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis1 , 2006, The Journal of Immunology.

[12]  J. Kwekkeboom,et al.  Low circulating regulatory T‐cell levels after acute rejection in liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[14]  R. V. van Lier,et al.  Differentiation of Human Alloreactive CD4+ and CD8+ T Cells In Vitro , 2004, Transplantation.

[15]  D. Mancini,et al.  Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. , 2004, International immunology.

[16]  A. Fietta,et al.  Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome , 2004, Transplantation.

[17]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[18]  M. Karim,et al.  CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.

[19]  F. Claas,et al.  Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection. , 1996, Transplantation.

[20]  M. Schilham,et al.  Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. , 2005, Human immunology.

[21]  Silviu Itescu,et al.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  G. Vlad,et al.  Regulatory CD8+CD28- T cells in heart transplant recipients. , 2003, Human immunology.